Gland Pharma Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Current Ratio | 8.40 | 8.33 | 8.53 | 7.74 | 4.82 |
Fixed Assets | 1.71 | 1.65 | 2.51 | 2.49 | 2.05 |
Inventory | 2.60 | 2.31 | 3.58 | 3.41 | 3.16 |
Debtors | 4.10 | 3.73 | 5.04 | 5.44 | 4.75 |
Interest Cover Ratio | 180.27 | 142.49 | 309.98 | 392.45 | 139.28 |
PBIDTM (%) | 37.80 | 33.25 | 39.42 | 41.50 | 41.57 |
PBITM (%) | 33.91 | 29.19 | 36.91 | 38.65 | 37.98 |
PBDTM (%) | 37.62 | 33.05 | 39.30 | 41.40 | 41.30 |
CPM (%) | 28.93 | 25.51 | 30.05 | 31.64 | 32.94 |
APATM (%) | 25.04 | 21.45 | 27.54 | 28.79 | 29.35 |
ROCE (%) | 16.65 | 13.96 | 24.85 | 27.99 | 30.60 |
RONW (%) | 12.31 | 10.27 | 18.56 | 20.88 | 23.75 |